Navigation Links
Grupo Casa Saba Announces Quarterly Earnings Report 2Q09
Date:7/27/2009

of 2008.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents at the end of the second quarter of 2009 was $199.15 million.

COMPREHENSIVE COST OF FINANCING

During the period, GCS's comprehensive cost of financing (CCF) rose to $58.63 million. This was primarily due to an increase in the amount of interest income paid.

These interest payments are related to the long-term credit that was obtained as a result of the acquisition in Brazil as well as the interest that was generated from the utilization of short-term credits for our operations in both Mexico and Brazil.

OTHER EXPENSES (INCOME)

During the second quarter of 2009, the Company registered an income of $2.26 million in other expenses (income). The expenses (income) from this line item were derived from activities that are distinct from the company's everyday business operations.

TAX PROVISIONS

During the second quarter, tax provisions rose to $43.72 million, $55.04 million of which were related to income tax payments and ($11.32) million were attributed to deferred income tax.

NET INCOME

GCS's net income for the second quarter was $147.03 million, a decrease of 30.02% compared to the second quarter of 2008.

The net margin for the period was 1.94%, a decline from the 3.02% net margin registered during the second quarter of 2008.

WORKING CAPITAL

During the second quarter of 2009, our accounts receivable days increased by 7.2 days from 2Q08 to reach 67.8 days. In addition, our accounts payable days rose by 4.0 days versus 2Q08, to reach 52.0 days. Finally, our inventory days were 55.0 days, an increase of 1.1 days compared to the same period of the previous year.

    Contacts:

    GRUPO CASA SABA
    Patrik Zielinski
    +52 (55) 5284-6623
    '/>"/>
SOURCE Grupo Casa Saba
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Grupo Casa Saba Announces Third Quarter 2007 Results
2. Grupo Casa Saba Announces Fourth Quarter 2007 Results
3. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
4. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
5. Grupo Casa Saba Quarterly Earnings Report 3Q08
6. Grupo Casa Saba Announces 4Q08 Earnings Results
7. Grupo Aeroportuario del Pacifico, S.A.B. de C.V. Announcement Regarding Swine Flu Virus
8. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
9. Grupo Salinas, Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti-Litter and Recycling Contests
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMedic...ing(MRI)coilsandsoftwareandCalgaryScientificInc.,a...introducedawebversionofAegis(TM)Breast4DAdvancedVi...isthefirsttrulyzero-footprintWebclientbasedmedical...Web(TM)platformallowsforzero-footprintaccess-requi...
(Date:11/25/2009)...LVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anar...forDrugEvaluationandResearch,titled"ADifficultBala...theNov.26,2009issueofTheNewEnglandJournalofMedicin...h/20090824/FDALOGO ) ,, Inthearticle,Woodcockdi...inmedicationforthosewhoneeditandmanagingtheriskspo...
(Date:11/25/2009)...roadPoliticalEndorsements,Business,andPressJoinEff...e-USNewswire/--Onceagain,theNationalBipolarFoundat...ndorsingtheir"Safe,tilStable"program,whichisnowbei...ipolardisorder.Today,theNationalBipolarFoundationr...PriorityMailfromtheLt.GovernorofLouisianaMitchLand...
(Date:11/25/2009)...uitous discovery that grew out of a collaboration ...ially offer hope to the nearly 10 million American... , Also known as hardening of the arteries, peri...latory problem in which narrowed arteries reduce b...d a red flag for vascular disease, heart attack an...
(Date:11/25/2009)... already used to fight rheumatoid arthritis, could... , WEDNESDAY, Nov. 25 (HealthDay News) -- A ... and rheumatoid arthritis now also shows some prom...1 diabetes. , The drug, rituximab (Rituxan), he...ulin, even though the disease had destroyed some o...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...acid supplements may slow cognitive decline in som... do not appear// to affect those with more advance... Alzheimer’s disease is a severely debilitati... according to background information in the articl...
... the ruling by Maryland's highest court a group of... state's medical// assistance program by Republica...The Court of Appeals voted unanimously that Ehrlic...ldren and pregnant women who were recent but legal...
...strict the use animals for the purpose of drug tes... are being developed by researchers at the Univers...130,000? as a financial grant. Gauging the ca...ety. Gentronix , a research company founded by ...
... a decline in the incidence of stroke in Perth, We...ding to new research// announced today by The Geor...l Scientific Meeting of the Stroke Society of Aust...tionally, over 53,000 strokes occur each year, of ...
...are provided by doctors and dentists according to ... which runs Barrowa€?s Furness General Hospital is...re Commission has roundly criticised the NHS servi...erformance of NHS in relation to government target...
...ut down the neo-natal intensive care unit of the R...immediate //effect was passed by the Philippine He...ts of the death of seven new born babies. Th...-natal sepsis”. . An inspection control commi...
Other Medicine News:Health News:Omega-3 May Slow Cognitive Decline in Some with Very Mild Alzheimer’ 2Health News:Health Care Benefits for Immigrants Favored by MD Court 2Health News:Grant Encourages Drug Testing Sans Animals 2Health News:Declining Incidence of stroke in Australia 2
(Date:11/25/2009)...wire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),ac...ering,developingandcommercializingnoveldrugstotrea...calyearendedSeptember30,2009.AtSeptember30,2009Pha...ortterminvestments. ,, PipelineUpdateand2009Hi..., InlateNovember2009,anindependentDataMonitoring...
(Date:11/25/2009)...--BioTrendsResearchGroup,Inc.releasedWave1ofits L...ti-phasesyndicatedmarketresearchprojecttrackingthe...launchthroughthefirstsixmonthsofavailability.Eachw...5uniqueDermatologistsandqualitativeinformationfrom...bstaclestouse,typicalpatienttypes,productperceptio...
(Date:11/25/2009)...swire-USNewswire/--RemediumTechnologiesInc.,acompa...leeding,wonfirstprizeand$10,000intheMostPromisingS...9,companyofficialsannouncetoday. ,, Selectedfro...ampitchedtheirinventionattheGSCSecuritySummitconfe...um( www.remediumtechnologies.com )isdevelopingahig...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3BioFlu Could This Be The Natural Defence Against Swine Flu 3F 54947 1BioFlu Could This Be The Natural Defence Against Swine Flu 3F 54947 2BioFlu Could This Be The Natural Defence Against Swine Flu 3F 54947 3Synthesis and Purification of Peptide Libraries Innovative Approaches 13634 1Synthesis and Purification of Peptide Libraries Innovative Approaches 13634 2Florida Spine Surgeon Alfred Bonati M D Announces Results of National Poll Showing America 26apos 3Bs Doctors Oppose a Government Run Health Care Pl 54942 1Florida Spine Surgeon Alfred Bonati M D Announces Results of National Poll Showing America 26apos 3Bs Doctors Oppose a Government Run Health Care Pl 54942 2
... NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - ImClone ...ers Squibb Company (NYSE:,BMY) announced today tha...ximab) combined with platinum-based chemotherapy,m...ival in patients,with recurrent and/or metastatic ...N). The randomized, multi-center study, known as,E...
... COLLEGEVILLE, Pa., April 03, 2007 /PRNewswire-Fi...yeth , provides comment on a,re- analysis of poole...,s Health Initiative (WHI) Study published today i... The pooled analysis,showed no apparent increase i...rmone therapy close to menopause. , The publicatio...
Other Medicine Technology:Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 2Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 3Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 4Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 5Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 6Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 7Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 8New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 2New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 3New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 4New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 5New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 6
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: